12/4
06:27 pm
mbx
MBX Biosciences (MBX) Is Down 9.7% After Goldman Sell Call and MPM Exit - What's Changed [Yahoo! Finance]
Low
Report
MBX Biosciences (MBX) Is Down 9.7% After Goldman Sell Call and MPM Exit - What's Changed [Yahoo! Finance]
12/4
08:04 am
mbx
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $18.00 price target on the stock.
Low
Report
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $18.00 price target on the stock.
12/1
12:37 pm
mbx
Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus [Yahoo! Finance]
Medium
Report
Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus [Yahoo! Finance]
12/1
11:38 am
mbx
How Much Upside is Left in MBX Biosciences, Inc. (MBX)? Wall Street Analysts Think 80.6% [Yahoo! Finance]
Low
Report
How Much Upside is Left in MBX Biosciences, Inc. (MBX)? Wall Street Analysts Think 80.6% [Yahoo! Finance]
11/27
07:07 pm
mbx
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones [Yahoo! Finance]
Low
Report
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones [Yahoo! Finance]
11/18
08:42 am
mbx
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference [Yahoo! Finance]
Medium
Report
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference [Yahoo! Finance]
11/18
08:00 am
mbx
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference
Medium
Report
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference
11/10
10:04 am
mbx
MBX Biosciences (NASDAQ:MBX) had its price target lowered by analysts at Guggenheim from $84.00 to $77.00. They now have a "buy" rating on the stock.
Low
Report
MBX Biosciences (NASDAQ:MBX) had its price target lowered by analysts at Guggenheim from $84.00 to $77.00. They now have a "buy" rating on the stock.
11/6
08:00 am
mbx
MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Medium
Report
MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
11/4
08:09 am
mbx
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Low
Report
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
11/4
07:21 am
mbx
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
Low
Report
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
10/20
08:00 am
mbx
MBX Biosciences to Participate in November Investor Conferences
Medium
Report
MBX Biosciences to Participate in November Investor Conferences
10/15
08:12 am
mbx
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $50.00 price target on the stock.
Low
Report
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $50.00 price target on the stock.
9/29
08:00 am
mbx
MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum
Low
Report
MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum
9/25
06:26 am
mbx
MBX Biosciences, Inc. (MBX) Discusses On Topline Results From Avail Phase 2 Trial Transcript [Seeking Alpha]
High
Report
MBX Biosciences, Inc. (MBX) Discusses On Topline Results From Avail Phase 2 Trial Transcript [Seeking Alpha]
9/24
09:28 pm
mbx
MBX Biosciences, Inc. - Special Call [Seeking Alpha]
High
Report
MBX Biosciences, Inc. - Special Call [Seeking Alpha]
9/24
09:15 pm
mbx
MBX Biosciences Announces Pricing of Upsized Public Offering
High
Report
MBX Biosciences Announces Pricing of Upsized Public Offering
9/24
09:54 am
mbx
MBX Biosciences (NYSE:MBX) had its price target raised by analysts at Mizuho from $38.00 to $56.00. They now have an "outperform" rating on the stock.
Medium
Report
MBX Biosciences (NYSE:MBX) had its price target raised by analysts at Mizuho from $38.00 to $56.00. They now have an "outperform" rating on the stock.
9/23
07:38 am
mbx
MBX Biosciences (MBX) Is Up 84.0% After Positive Phase 2 Results for Canvuparatide - Has The Bull Case Changed? [Yahoo! Finance]
Medium
Report
MBX Biosciences (MBX) Is Up 84.0% After Positive Phase 2 Results for Canvuparatide - Has The Bull Case Changed? [Yahoo! Finance]
9/23
03:02 am
mbx
MBX Biosciences (NYSE:MBX) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
MBX Biosciences (NYSE:MBX) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
9/23
03:02 am
mbx
MBX Biosciences (NYSE:MBX) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Medium
Report
MBX Biosciences (NYSE:MBX) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
9/22
04:27 pm
mbx
MBX Biosciences files for public offering of 10M shares [Seeking Alpha]
Low
Report
MBX Biosciences files for public offering of 10M shares [Seeking Alpha]
9/22
04:23 pm
mbx
MBX Biosciences Announces Proposed Public Offering [Yahoo! Finance]
Low
Report
MBX Biosciences Announces Proposed Public Offering [Yahoo! Finance]
9/22
04:14 pm
mbx
MBX Biosciences Announces Proposed Public Offering
Low
Report
MBX Biosciences Announces Proposed Public Offering
9/22
08:44 am
mbx
MBX Biosciences' Experimental Drug Shows Promise In Hypoparathyroidism Study [Yahoo! Finance]
High
Report
MBX Biosciences' Experimental Drug Shows Promise In Hypoparathyroidism Study [Yahoo! Finance]